Kaiser Permanente officials announced Tuesday that they are expanding COVID-19 vaccine trials to include children ages 5-11 in Oakland, Santa Clara and Sacramento. The three trial sites on Monday began enrolling roughly 75 children in the 5-11 age range. Kaiser’s
Roughly 4,600 children are participating in trials across the country to determine the vaccine s safety and efficacy in children under 12. There s a lot of vigorous interest right now in terms of availability and there s limited availability for the study, said Vaccine Study Center Director Dr. Nicky Klein.
Kaiser s Vaccine Study Center also participated in the clinical trials to determine the safety and efficacy of the Pfizer vaccine both in adults and children ages 12-17.
In the coming weeks, trials are also likely to open for children under age 5, Klein said, as logistics and finer details are still being worked out. Eventually, she said, medical experts intend to recommend that all children receive the vaccine once it is available to them.
Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.